Evidence map›Paper›PMID 28066173›Full record

ArticleFrontiers in molecular neuroscience2016

Protective Effect of Minocycline Against Ketamine-Induced Injury in Neural Stem Cell: Involvement of PI3K/Akt and Gsk-3 Beta Pathway.

Yang Lu, Shan Lei, Ning Wang, Pan Lu, Weisong Li, Juan Zheng, Praveen K Giri, Haixia Lu, Xinlin Chen, Zhiyi Zuo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Yang LuDepartment of Anesthesiology, The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an, China.
Shan LeiDepartment of Anesthesiology, The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an, China.
Ning WangDepartment of Anesthesiology, The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an, China.
Pan LuDepartment of Anesthesiology, The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an, China.
Weisong LiDepartment of Anesthesiology, The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an, China.
Juan ZhengDepartment of Anesthesiology, The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an, China.
Praveen K GiriDepartment of Anesthesiology, The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an, China.
Haixia LuInstitute of Neurobiology, National Key Academic Subject of Physiology of Xi'an Jiaotong University Xi'an, China.
Xinlin ChenInstitute of Neurobiology, National Key Academic Subject of Physiology of Xi'an Jiaotong University Xi'an, China.
Zhiyi ZuoDepartment of Anesthesiology, University of Virginia Charlottesville, VA, USA.
Yong LiuInstitute of Neurobiology, National Key Academic Subject of Physiology of Xi'an Jiaotong University Xi'an, China.
Pengbo ZhangDepartment of Anesthesiology, The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an, China.
Second Affiliated Hospital of Xi'an Jiaotong University · CNXi'an Jiaotong University · CNUniversity of Virginia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been suggested that ketamine cause injury during developing brain. Minocycline (MC) could prevent neuronal cell death through the activation of cell survival signals and the inhibition of apoptotic signals in models of neurodegenerative diseases. Here we investigated the protective effect of MC against ketamine-induced injury in neural stem cells (NSCs) from neonatal rat. Ketamine (100 μM/L) significantly inhibited NSC proliferation, promoted their differentiation into astrocytes and suppressed neuronal differentiation of NSCs. Moreover, the apoptotic level was increased following ketamine exposure. MC pretreatment greatly enhanced cell viability, decreased caspase-3-like activity, even reversed the differentiation changes caused by ketamine. To elucidate a possible mechanism of MC' neuroprotective effect, we investigated the phosphatidylinositol 3-kinase (PI3K) pathway using LY294002, a specific PI3K inhibitor. Immunoblotting revealed that MC enhanced the phosphorylation/activation of Akt and phosphorylation/inactivation of glycogen synthase kinase-3beta (Gsk-3β). Our results suggest that PI3K/Akt and Gsk-3β pathway are involved in the neuroprotective effect of MC.

Indexed as

Aktcaspase-3Gsk-3βketamineminocyclineneural stem cellsneuroprotective effect

Identifiers

PMID28066173
PMCPMC5167749
OpenAlexW2562328371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.